2026 Bowen_Headshot (Red Dress).png
2026 Bowen_Headshot (Red Dress).png

Eosinophilic Esophagitis Part 2

$39.00

Members: FREE

Login to your member account, click “Account” in the top right hand corner and click “View” under “GastroANP Members” to find the coupon code to be entered at checkout!

Non-members: $39

A Zoom link will be sent to your registered email the week of the event.

Date: 4/8/26 Time: 5:30PM PDT

Learning Objectives.

  1. Describe current diagnostic criteria and monitoring strategies for eosinophilic esophagitis (EoE), including biopsy protocols and endoscopic scoring tools.

  2. Compare major treatment strategies including pharmacologic therapy, dietary elimination approaches, biologic therapies, and esophageal dilation.

  3. Apply treat-to-target management principles that incorporate symptoms, histology, and structural disease assessment.

  4. Recognize emerging therapies and monitoring approaches, including biologic medications and minimally invasive disease monitoring tools.

  5. Integrate multidisciplinary and whole-person strategies to improve long-term outcomes and quality of life in patients with eosinophilic esophagitis.

Members: FREE

Login to your member account, click “Account” in the top right hand corner and click “View” under “GastroANP Members” to find the coupon code to be entered at checkout!

Non-members: $39

A Zoom link will be sent to your registered email the week of the event.

Date: 4/8/26 Time: 5:30PM PDT

Learning Objectives.

  1. Describe current diagnostic criteria and monitoring strategies for eosinophilic esophagitis (EoE), including biopsy protocols and endoscopic scoring tools.

  2. Compare major treatment strategies including pharmacologic therapy, dietary elimination approaches, biologic therapies, and esophageal dilation.

  3. Apply treat-to-target management principles that incorporate symptoms, histology, and structural disease assessment.

  4. Recognize emerging therapies and monitoring approaches, including biologic medications and minimally invasive disease monitoring tools.

  5. Integrate multidisciplinary and whole-person strategies to improve long-term outcomes and quality of life in patients with eosinophilic esophagitis.